A detailed history of Sargent Bickham Lagudis LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 95 shares of ILMN stock, worth $13,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 95 -0.0%
Holding current value
$13,694
Previous $18,000 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$177.23 - $227.44 $72,309 - $92,795
-408 Reduced 81.11%
95 $18,000
Q2 2022

Jul 13, 2022

BUY
$181.58 - $368.0 $14,344 - $29,072
79 Added 18.63%
503 $93,000
Q1 2022

Apr 27, 2022

SELL
$303.87 - $423.8 $7,596 - $10,595
-25 Reduced 5.57%
424 $148,000
Q4 2021

Jan 18, 2022

BUY
$347.28 - $421.83 $8,682 - $10,545
25 Added 5.9%
449 $171,000
Q1 2021

May 24, 2021

SELL
$361.28 - $504.76 $1,806 - $2,523
-5 Reduced 1.17%
424 $163,000
Q4 2020

May 24, 2021

BUY
$292.7 - $370.96 $1,463 - $1,854
5 Added 1.18%
429 $159,000
Q4 2020

May 24, 2021

BUY
$292.7 - $370.96 $292 - $370
1 Added 0.24%
424 $163,000
Q2 2020

Sep 07, 2021

SELL
$256.46 - $373.01 $11,540 - $16,785
-45 Reduced 9.62%
423 $157,000
Q1 2020

Sep 07, 2021

BUY
$209.2 - $335.53 $22,593 - $36,237
108 Added 30.0%
468 $128,000
Q2 2018

Sep 13, 2021

BUY
$228.17 - $292.07 $22,817 - $29,207
100 Added 38.46%
360 $101,000
Q1 2018

Sep 13, 2021

BUY
$209.54 - $253.91 $54,480 - $66,016
260 New
260 $61,000
Q3 2017

Sep 13, 2021

SELL
$172.3 - $213.93 $1,550 - $1,925
-9 Closed
0 $0
Q2 2017

Sep 13, 2021

BUY
N/A
9 New
9 $2,000
Q4 2016

Sep 13, 2021

SELL
N/A
-22 Closed
0 $0
Q1 2016

Sep 07, 2021

BUY
N/A
22
22 $4,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.